Shrm Consulting Services Agreement

Posted by on Oct 8, 2021 in Uncategorized | No Comments

A human resources consultant contract is a service contract between an HR specialist and his client. Once completed, the form contains all the convincing details of the agreement, including the services provided, remuneration, payment, expenses and the duration of the duration for which the advisor is engaged. Prohibitions of competition and prohibitions of debauchery are also included in the document that prevents the consultant from working for a certain period of time for a competitor or client of the client. In addition, the status of the consultant as an independent contractor and the responsibility to pay taxes on all income are indicated in the agreement as clarification and protection of the client against any liability. According to the Bureau of Labor Statistics (BLS), the average annual salary for consultants was $90,860 in May 2014, showing that companies and organizations are willing to pay a premium for the services of qualified human resources consultants. The top 10 percent in this occupation earn more than US$148,110, the BLS reports. 6.1 xxxx warrants that the services to be provided under this Agreement are provided in a professional manner and in accordance with generally recognized industry standards and practices. (company name) agrees that xxxx is the sole and exclusive obligation for the services covered by this limited warranty, at xxxx`s sole discretion, to correct the non-compliance or refund the service fees paid for the relevant consulting services. The Company also announces that it has commissioned Gold Standard Media, LLC (“GSM”) to provide marketing and consulting services to raise public awareness of the company, with a particular focus on the company`s clinical expansion in North America. GSM is a limited liability company under the laws of the State of Texas, based at 1102 p. Austin Ave, #110-283, Georgetown, Texas, USA.

Champignon Brands (CSE: SHRM) focuses on the formulation and manufacture of novel ketamine, anesthetic and adaptogen platforms for nutraceutical and psychedelic medicine and is supported by a state-of-the-art clinical platform for psychedelic drugs. The company tracks the evolution and commercialization of high-speed treatments that can improve health outcomes such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. As part of a joint research agreement with the University of Miami`s Miller School of Medicine, the company is conducting preclinical studies and possible human clinical trials to demonstrate the safety and efficacy of the combination of psilocybin and cannabidiol in the treatment of mTBI with PTSD or stand-alone PTSD. . . .